J X Yang
Overview
Explore the profile of J X Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song X, Zhang H, Zhong S, Tan X, Ma S, Jin Y, et al.
Zhonghua Fu Chan Ke Za Zhi
. 2024 Mar;
59(3):200-209.
PMID: 38544449
To evaluate the surgery combined chemotherapy and radiation in locally advanced neuroendocrine carcinoma of the cervix (NECC) . This is a single-center retrospective cohort study. Locally advanced NECC patients admitted...
2.
Yang J, Lang J
Zhonghua Fu Chan Ke Za Zhi
. 2024 Feb;
59(2):118-120.
PMID: 38389230
No abstract available.
3.
Liang H, Li S, Yang J, Wu M, Cao D, Wang J, et al.
Zhonghua Fu Chan Ke Za Zhi
. 2024 Jan;
59(1):64-69.
PMID: 38228517
To evaluate the incidence, treatment, and survival outcomes of Swyer syndrome with gonadal non-dysgerminoma malignant germ cell tumor (MGCT-NDG). A retrospective study was performed on Swyer syndrome patients with MGCT-NDG...
4.
Zhang X, Yang J, Xiang Y, Wu M, Pan L, Yang J
Zhonghua Fu Chan Ke Za Zhi
. 2023 Nov;
58(11):838-845.
PMID: 37981770
To compare the survival outcomes between surveillance and adjuvant chemotherapy in patients with stage Ⅰ ovarian immature teratoma (IMT) underwent fertility-sparing surgery. Clinical and pathological records of patients with stage...
5.
Song X, Zhang H, Zhong S, Tan X, Ma S, Jin Y, et al.
Zhonghua Fu Chan Ke Za Zhi
. 2023 Sep;
58(9):680-690.
PMID: 37724385
To evaluate the effect of postoperative radiotherapy and high-risk pathological factors on the prognosis of early-stage neuroendocrine carcinoma of cervix (NECC). A single-center retrospective cohort study of early-stage NECC in...
6.
Yang J, Ma N, Chen G, Li X, Liu N, Tang R, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
. 2022 Sep;
50(9):923-925.
PMID: 36096712
No abstract available.
7.
Huo P, Xu J, He L, Meng B, Yang J, Zhu D, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi
. 2022 Jul;
57(7):716-723.
PMID: 35790511
To analyze the influences of leukocytes on improving blood glucose control in patients with type 2 diabetes mellitus (T2DM) and periodontitis after periodontal mechanical therapy. Thirty-five patients visiting Peking University...
8.
Su Y, Yang J, Hu Y, Liu Y, Xu H, Hu S, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
. 2021 Dec;
56(12):1361-1365.
PMID: 34963229
No abstract available.
9.
Chen J, Cao D, Zhou H, Yu M, Yang J, Wang J, et al.
Zhonghua Fu Chan Ke Za Zhi
. 2021 Aug;
56(8):561-568.
PMID: 34420288
To analyze the clinical efficacy and pregnancy outcomes of gonadotropin-releasing hormone agonist (GnRH-a) based fertility-sparing re-treatment in women with endometrial carcinoma (EC) and atypical endometrial hyperplasia (AEH) who failed with...
10.
Wu X, Zhu J, Yin R, Yang J, Liu J, Wang J, et al.
Ann Oncol
. 2021 Jan;
32(4):512-521.
PMID: 33453391
Background: This study evaluated maintenance treatment with niraparib, a potent inhibitor of poly(ADP-ribose) polymerase 1/2, in patients with platinum-sensitive recurrent ovarian cancer. Patients And Methods: In this phase III, double-blind,...